Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumors display divergent genomic and transcriptomic profiles-Reference-Cited by-同舟云学术

Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumors display divergent genomic and transcriptomic profiles

Published:2021-12-02 Issue:12 Volume:25 Page:1095-1105
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Simbolo Michele¹,Bersani Samantha¹,Vicentini Caterina²,Taormina Sergio V.¹,Ciaparrone Chiara¹,Bagante Fabio³,Rusev Borislav¹²,Centonze Giovanni⁴,Montresor Marina¹,Brunelli Matteo¹,Pedron Serena¹,Mafficini Andrea¹²,Paolino Gaetano¹,Mattiolo Paola¹,Conci Simone³,Milione Massimo⁴,Guglielmi Alfredo³,Ruzzenente Andrea³,Scarpa Aldo¹²,Luchini Claudio¹²^ORCID

Affiliation:

1. Department of Diagnostics and Public Health, Section of Pathology, University and Hospital Trust of Verona, Verona, Italy

2. ARC-Net Research Center, University and Hospital Trust of Verona, Verona, Italy

3. Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Unit of General and Hepatobiliary Surgery, University and Hospital Trust of Verona, Verona, Italy

4. Pathology Unit, Foundation IRCCS, Istituto Nazionale Tumori, Milano, Italy

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2021.2013801

Reference56 articles.

1. Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site

2. Analysis of incidence, mortality and survival for pancreatic and biliary tract cancers across Europe, with assessment of influence of revised European age standardisation on estimates

3. Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors?

4. Extrahepatic cholangiocarcinoma: Current status of endoscopic approach and additional therapies

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholangiocarcinoma;Treatment and Management of Tropical Liver Disease;2025

2. The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell’Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO);Tumori Journal;2024-02-07

3. Evaluation of potential targets to enhance the sensitivity of cholangiocarcinoma cells to anticancer drugs;Biomedicine & Pharmacotherapy;2023-12

4. Establishment and characterization of a novel hilar cholangiocarcinoma cell line, CBC3T-1;Human Cell;2023-11-15

5. Establishment and characterization of a novel hilar cholangiocarcinoma cell line, CBC3T-1;2023-09-21